University of Texas/Texas AM Investment Management Co (UTIMCO)’s Bristol-Myers Squibb BMY Stock Holding History
Other funds holding BMY
University of Texas/Texas AM Investment Management Co (UTIMCO)'s BMY Position: Q2 2026 in Review
University of Texas/Texas AM Investment Management Co (UTIMCO) opened a new position in Bristol-Myers Squibb (BMY) in Q2 2026: 1,460 shares worth $84.1K. The stake represents 0.01% of the portfolio and ranks #230 among its holdings. This is a return to the name: University of Texas/Texas AM Investment Management Co (UTIMCO) previously reported a position in BMY as recently as Q4 2025.
University of Texas/Texas AM Investment Management Co (UTIMCO) first reported a position in BMY in Q3 2014 and has held it in 6 quarters since. The position peaked at $4.14M in Q4 2025. 1,985 funds tracked by Wall St. Rank hold BMY as of Q2 2026.
- University of Texas/Texas AM Investment Management Co (UTIMCO) held 1,460 shares of Bristol-Myers Squibb worth $84.1K as of Q2 2026.
- Bristol-Myers Squibb was a new University of Texas/Texas AM Investment Management Co (UTIMCO) position in Q2 2026.
- Bristol-Myers Squibb made up 0.01% of University of Texas/Texas AM Investment Management Co (UTIMCO)'s portfolio in Q2 2026, its #230 holding.
- University of Texas/Texas AM Investment Management Co (UTIMCO) first reported a position in Bristol-Myers Squibb in Q3 2014 and has held it in 6 quarters since.
- University of Texas/Texas AM Investment Management Co (UTIMCO)'s Bristol-Myers Squibb position peaked at $4.14M in Q4 2025.
- 1,985 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.
Based on University of Texas/Texas AM Investment Management Co (UTIMCO)'s 13F filing for Q2 2026, filed 3 Aug 2026.